Canilang, Baby Boy .
HRN: 25-29-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
06/16/2024
06/22/2024
IV
14.5mg
OD
Potentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes